David Fajgenbaum, MD, MBA, of the University of Pennsylvania, talks about his research efforts to find an already-approved drug that could treat his orphan disease—multicentric Castleman disease—and h...
Giuseppe Curigliano, MD, PhD, of the University of Milan and Istituto Europeo Oncologico, talks about designing public health measures focused on COVID-19 morbidity and mortality for cancer patients, ...
Antoni Ribas, MD, PhD, of the University of California, Los Angeles and Jonsson Comprehensive Cancer Center, and President of the American Association for Cancer Research, talks about why the meeting ...
Toni K. Choueiri, MD, of Dana-Farber Cancer Institute, discusses the challenges of delivering optimal cancer treatments in the face of the coronavirus pandemic. Focusing on systemic therapies, he revi...